| Literature DB >> 28105278 |
Jolanta Dyniewicz1, Piotr F J Lipiński1, Piotr Kosson1, Anna Leśniak1, Marta Bochyńska-Czyż1, Adriana Muchowska1, Dirk Tourwé2, Steven Ballet2, Aleksandra Misicka1, Andrzej W Lipkowski1.
Abstract
The area of multitarget compounds, joining two pharmacophores within one molecule, is a vivid field of research in medicinal chemistry. Not only pharmacophoric elements are essential for the design and activity of such compounds, but the type and length of linkers used to connect them are also crucial. In the present contribution, we describe compound 1 in which a typical opioid peptide sequence is combined with a fragment characteristic for neurokinin-1 receptor (NK1R) antagonists through a hydrazone bridge. The compound has a high affinity for μ- and δ-opioid receptors (IC50= 12.7 and 74.0 nM, respectively) and a weak affinity for the NK1R. Molecular modeling and structural considerations explain the observed activities. In in vivo test, intrathecal and intravenous administrations of 1 exhibited a strong analgesic effect, which indicates potential BBB penetration. This letter brings an exemplary application of the hydrazone linker for fast, facile, and successful preparation of chimeric compounds.Entities:
Keywords: Bifunctional ligands; NK1 antagonists; hydrazone linker; opioid agonists
Year: 2016 PMID: 28105278 PMCID: PMC5238479 DOI: 10.1021/acsmedchemlett.6b00381
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345